Patent Settlements, Stock Price Movements, and Financial Guidance - Research
Report on Pfizer, Tenet, Rockwell Medical, Magellan Health Services, and
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, December 20, 2013
NEW YORK, December 20, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Pfizer
Inc. (NYSE: PFE), Tenet Healthcare Corp. (NYSE: THC), Rockwell Medical Inc.
(NASDAQ: RMTI), Magellan Health Services Inc. (NASDAQ: MGLN), and HealthSouth
Corp. (NYSE: HLS). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
Pfizer Inc. Research Report
On December 17, 2013, Pfizer Inc. (Pfizer) announced that the Company has
settled its litigation against Teva Pharmaceuticals, USA Inc. (Teva) regarding
Pfizer's patent covering the use of Viagra to treat erectile dysfunction
(sildenafil citrate 25, 50, and 100 mg tablets) which expires in April 2020
(including pediatric exclusivity). Pfizer reported that Teva will be allowed
to launch a generic version of Viagra in the US on December 11, 2017 or
earlier under certain circumstances, as a result of the settlement. Further,
Pfizer informed that Teva will pay the Company a royalty for a license to
produce Viagra's generic version. The Full Research Report on Pfizer Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
Tenet Healthcare Corp. Research Report
On December 17, 2013, Tenet Healthcare Corp.'s (Tenet) stock declined 1.85%,
ending the day at $39.86. Over the previous three trading sessions, shares of
Tenet declined 1.39%, compared to the S&P 500 which gained 0.31% during the
same period. The Full Research Report on Tenet Healthcare Corp. - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
Rockwell Medical Inc. Research Report
On December 17, 2013, Rockwell Medical Inc.'s (Rockwell Medical) stock
declined 19.82%, ending the day at $10.80. Over the previous three trading
sessions, shares of Rockwell Medical declined 20.47%, compared to the Nasdaq
Composite which gained 0.63% during the same period. The Full Research Report
on Rockwell Medical Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
Magellan Health Services Inc. Research Report
On December 17, 2013, Magellan Health Services Inc. (Magellan Health Services)
announced that for full-year 2014, the Company expects to generate net revenue
in the range of $3.6 billion to $3.8 billion, and net income in the range of
$57 million to $73 million or $2.00 to $2.56 per diluted share, inclusive of
share repurchases to date and the effect of the Affordable Care Act (ACA) tax.
In addition, Magellan Health Services reported that it expects segment profit
for full-year 2014 to be in the range of $215 million to $235 million. Jon N.
Rubin, Chief Financial Officer of Magellan Health Services, said, "The next
year will be a transitional year for us. By the end of 2014, we anticipate a
more stable customer base from which we can achieve earnings growth in future
years, with significant contributions from our Magellan Complete Care and
Magellan Pharmacy Solutions businesses. Beyond 2014, we are optimistic about
our future, targeting a long-term compound annual growth rate in both revenue
and earnings per share of 20 percent." The Full Research Report on Magellan
Health Services Inc. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:
HealthSouth Corp. Research Report
On December 17, 2013, HealthSouth Corp. (HealthSouth) announced that the
Company will take part in the 32^nd Annual J.P. Morgan Healthcare Conference
in San Francisco on January 13, 2014 to January 16, 2014. The Company added
that HealthSouth President and CEO, Jay Grinney, is scheduled to speak on
January 14, 2014 at 10:30 a.m. PT/1:30 p.m. ET. The Company added that
interested parties may listen to live webcast by visiting HealthSouth's
Investor Relations website and clicking on an available link. The Full
Research Report on HealthSouth Corp. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
only human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
SOURCE Analysts' Corner
Contact: Joe Thomas, +1-310-496-8071 (North America)
Press spacebar to pause and continue. Press esc to stop.